| Financial Year |
March 31 2023 |
| Monetary Funds |
1,205,788,038.25 |
| Held-for-trading Financial Assets |
435,313,712.02 |
| Notes Receivable |
-- |
| Accounts Receivable |
349,580,801.87 |
| Advances to Suppliers |
9,979,337.63 |
| Other Receivables |
1,041,225.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
405,840,257.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
106,730,076.14 |
| Total Current Assets |
2,611,607,057.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
58,895,802.85 |
| Investment Properties |
57,964,023.08 |
| Fixed Assetes |
557,590,567.54 |
| Under-construction Projects |
57,985,071.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,556,408.10 |
| R&D expenses |
-- |
| Goodwill |
24,876,565.59 |
| Long-Term Deferred and Prepaid Expenses |
14,137,720.84 |
| Deferred Income Tax Assets |
12,147,680.29 |
| Other Non-Current Assets |
3,535,534.36 |
| Sub-Total of Non-Current Assets |
921,358,656.99 |
| Total Assets |
3,532,965,714.76 |
| Short-Term Loans |
79,062,080.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
301,813,124.14 |
| Accounts Payable |
253,059,447.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,553,734.40 |
| Taxes Payable |
12,377,145.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,726,735.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,140,980.91 |
| Other Current Liabilities |
577,569.64 |
| Sub-Total of Current Liabilities |
710,045,817.93 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,915,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
18,609,104.58 |
| Deferred Income Tax Liabilities |
21,598,584.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
133,507,741.81 |
| Total Liabilities |
843,553,559.74 |
| Paid-In Capital(Or Share Stock) |
871,554,818.00 |
| Capital Surplus |
414,931,015.59 |
| Surplus Reserve |
145,600,406.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,148,474,072.67 |
| Minority Stockholder's Interest |
108,851,842.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,580,560,312.57 |
| Owner's Equity（Stockholder's Equity） |
2,689,412,155.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,532,965,714.76 |
